This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Radiation-Induced Myelosuppression Treatment Market

Market Insights on Radiation-Induced Myelosuppression Treatment covering sales outlook, demand forecast & up-to-date key trends

Radiation-Induced Myelosuppression Treatment Market by Indication (Neutropenia, Anaemia, Thrombocytopenia), Drug Class (Growth Factors, Erythropoietin Stimulating Agents, Thrombopoietic Agents, Iron Supplements) & Region - Forecast 2022 - 2028

Radiation-Induced Myelosuppression Treatment Market Outlook : 2022-2028

[207 Pages Report]  Sales in the global Radiation-Induced Myelosuppression Treatment Market are slated to total US$ 2.9 Bn in 2022. Expanding at a steady 3.1% CAGR, the market valuation is projected to top US$ 3.5 Bn in 2028.

Attribute

Details

Radiation-Induced Myelosuppression Treatment Estimated Market Size 2022

US$ 2.9 Bn

Radiation-Induced Myelosuppression Treatment Market Value-based CAGR (2022-2028)

~3.1%

Radiation-Induced Myelosuppression Treatment Market Projected Size in 2028

US$ 3.5 Bn

Increasing incidence of cancer worldwide is underpinning the need for advanced cancer treatment options and therapies. Early diagnosis and the availability of radiotherapy and chemotherapy are expected to fuel sales in the market through 2031.

In addition to this, the introduction of adjuvant therapy for cancer is playing a vital role in reducing the death rate of cancer, improving disease management, and the overall quality of life in cancer patients. As per Future Market Insights, the market is projected to expand on the back of the aforementioned factors over the forecast period.

Customize this Report

Let us know your requirement to get
100% FREE customization

How The Market Progressed Till June 2022?

Particulars

Details

H1, 2021

3.42%

H1, 2022 Projected

3.12%

H1, 2022 Outlook

2.62%

BPS Change - H1, 2022 (O) – H1, 2022 (P)

(-) 50 ↓

BPS Change – H1, 2022 (O) – H1, 2021

(-) 80 ↓

Future Market Insights presents a comparative analysis about the market growth rates and development prospects in the global market. According to FMI analysis, the radiation-induced myelosuppression treatment market is expected to drop by 80 Basis Point Share (BPS) in H1- 2022 compared to H1-2021.

However, BPS change of only 50 BPS was observed when comparing H1-2022 Outlook and H1-2022 Projected growth. Key reason for this dip in BPS is attributed to the factor such as stringent government regulations and approval process for pipeline products, which impacted the growth of the market.

However, some positive factors which will influence the market growth in future include new developments and introduction of novel therapeutics for treatment of radiation induced myelosuppression. For instance, on Feb 2021, FDA approved trilaciclib (Cosela, G1 Therapeutics) for lowering the rate of chemotherapy-induced myelosuppression (CIM) in adult patients suffering from extensive-stage small-cell lung cancer (ES-SCLC).

2013-2021 Radiation-Induced Myelosuppression Treatment Market Outlook in Comparison to 2022-2028 Growth Forecast

Demand in the radiation-induced myelosuppression treatment market is projected to increase at a 3.1% CAGR, in comparison to the 3.4% CAGR registered between 2013 to 2031.

The availability of various growth factors and favorable treatment guidelines have made the management of neutropenia easier. However, thrombocytopenia and anemia are still posing a burden on the healthcare system.

Thrombocytopenia can be managed with the help of available growth factors, but most of them are off-label. The management of anemia remains a challenge for cancer patients who receive radiation therapy for cancer treatment.

Due to changes in reimbursement and labeling of medications for anemia, the use of off-label indication erythropoietin-stimulating agents has decreased to an extent. This has resulted in growing need for blood transfusion, which is associated with various risk factors.

Radiation-Induced Myelosuppression Treatment Market Download Report Brochure

This, in turn, is underscoring the significance of myelosuppression treatment therapeutics and drugs, which is expected to boost the market over the assessment period.

How is the Introduction of Novel Therapeutics for Myelosuppression Treatment Fueling Sales?

Anemia is a common consequence of chronic kidney diseases (CKD) and radiation-induced myelosuppression. Due to the insufficiency of erythropoietin synthesis, patients suffer from anemia. However, the combination of erythropoiesis-stimulating agents (ESA) and iron has become a standard treatment for anemia.

ESAs effectively increase the hemoglobin (Hb) levels in patients. However, their use has been associated with increased cardiovascular risk, especially due to high dose intake in inflamed and hyporesponsive patients.

Iron deficiency is another consequence of anemia. This has resulted in the introduction of intravenous iron therapy which is beneficial for anemic patients, CKD patients, and patients dealing with heart failure.

A new class of drugs, namely prolyl hydroxylase domain (PHD) inhibitors is now available for the treatment of anemia. These drugs effectively stimulate the synthesis of endogenous erythropoietin and increase iron availability.

In addition to this, in February, the U.S. Food and Drug Administration (FDA) approved Cosela (Trilaciclib) as the first line of treatment in its class to reduce the frequency of bone marrow suppression in adults, which is caused by chemotherapy for the extensive stage.

Such developments are expected to provide impetus to the growth of the market over the assessment period, opines FMI.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Country-wise Insights

What Will be the U.S. Radiation-Induced Myelosuppression Treatment Market Outlook?

“High Prevalence of Chemotherapy Induced Myelosuppression Will Spur Demand in the U.S.” 

The U.S. is expected to dominate the North America radiation-induced myelosuppression treatment market owing to growing incidence of cancer, chronic kidney diseases (CKD), and patients dealing with heart failure.

The presence of leading market players and fast-tracked approvals by the FDA are expected to augment the growth of the U.S. market. In addition to this, the U.S. is home to a vast healthcare sector, which is expected to provide opportunities for growth to market players over the assessment period.

What is Driving the China Radiation-Induced Myelosuppression Treatment Market?

“Healthcare Providers are Prescribing Myelosuppressive Chemotherapy Drugs To improve Bone Marrow Function”

China is expected to account for a lion’s share of the East Asia radiation-induced myelosuppression treatment market. Increasing geriatric population in the country, along with high incidence of cancer and heart failure are spurring the demand for myelosuppression treatment drugs.

Further, increasing research and development activities for the development of iron deficiency treatment is expected to augment the growth of the market. Iron deficiency is a consequence of anemia caused by chemotherapy radiation.

Growing preference for erythropoiesis-stimulating agents (ESAs) for iron deficiency in the country is anticipated to boost the market in the forthcoming years.

How Will the U.K. Radiation-Induced Myelosuppression Treatment Market Fare?

“Surging Trend of Medical Tourism Will Boost Sales of Myelosuppression Chemotherapy Drugs”

The U.K. is expected to emerge as a lucrative pocket in the Europe radiation-induced myelosuppression treatment market owing to the influx of medical tourists in the country, along with the availability of superior healthcare facilities.

Increasing adoption of technologically advanced medical equipment for the treatment of various chronic disorders such and cancer and kidney failure in the country is expected to augment the growth of the market in the forthcoming years.

Further, rising awareness regarding adjuvant treatment for cancer in the U.K. will continue boosting the market over the assessment period.

Category-wise Insights

Which Indication Segment is Most Lucrative?

“Surging Incidence of Neutropenia to Drive Preference for Myelosuppression Treatment Regimen”

Based on indication, sales in the neutropenia segment are projected to account for 43.3% of the total market share in 2022. Neutropenia is a condition where an individual deals with abnormally low counts of white blood cells.

Bone marrow malfunction caused by chemotherapy radiations is a chief factor driving sales in this segment. Lack of white blood cells in patients weakens the immune system and their ability to fight infections, which makes it imperative to seek treatment for the same.

Owing to the aforementioned factors, sales in this segment are projected to increase at a considerable pace over the assessment period.

Why is the Demand for Erythropoietin Stimulating Agents (ESAs) High?

 “Rising Awareness Regarding New Erythropoietin Stimulating Agents Will Bolster Sales”

In terms of drug class, demand in the erythropoietin stimulating agents (ESA) segment is projected to remain high over the assessment period. ESAs effectively improve the efficacy of iron therapy in anemic patients after chemotherapy radiations, which is expected to continue pushing sales in the market.

Besides this, growing preference for intravenous iron therapy with a combination of ESAs is expected to complement the growth of the market in the forthcoming years. The combination of ESAs and IV iron therapy improve the red blood cells count as compared to other treatment using ESAs alone.

Which is the Leading Distribution Channel and Route of Administration?

“Sales of Myelosuppression Chemotherapy Drugs to Remain High Via Hospital Pharmacies”

Based on the sales channel, sales in the hospital pharmacies segment are projected to increase at a considerable pace owing to the wide availability of therapeutic drugs in these shops. However, high convenience and timely delivery offered by online pharmacies will place them as a lucrative segment over the assessment period.

Which is the Preferred Route of Administration?

“Oral Route of Administration for Myelosuppression Chemotherapy Medication to Gain Traction”

In terms of route of administration, the oral route is expected to be preferred by both healthcare professionals and patients owing to ease of administration and high efficacy. Growing preference for non-invasive treatment options will also provide impetus to sales in this segment.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Competition Landscape

Leading players operating in the global radiation-induced myelosuppression treatment market are investing in research and development to improve lines of treatment for myelosuppression treatment. In addition to this, players are investing in mergers and acquisitions to strengthen their distribution channels.

Scope of Report

Attribute

Details

Forecast Period

2022-2028

Historical Data Available for

2013-2021

Market Analysis

Units for Volume and US$ Mn for Value

Key Regions Covered

North America, Latin America, Europe, East Asia, South Asia, Oceania, and MEA

Key Countries Covered

United States, Canada, Brazil, Mexico, Germany, UK, France, Italy, Spain, Nordic, Russia, Poland, China, India, Thailand, Indonesia, Australia and New Zealand, Japan, GCC countries, North Africa, South Africa, others.

Key Market Segments Covered

Indication, Drug Class, Route of Administration, Distribution Channel, and Region

Key Companies Profiled

  • Amgen Inc.
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd
  • Mylan N.V.
  • Pfizer Inc.
  • Janssen Global Services, LLC (Johnson & Johnson)
  • Partner Therapeutics, Inc.
  • Mission Pharmacal Company
  • Myelo Therapeutics GmbH
  • Pluristem Therapeutics Inc.

Pricing

Available upon Request

Radiation-Induced Myelosuppression Treatment Market by Category

Indication:

  • Neutropenia
  • Anemia
  • Thrombocytopenia

Drug Class:

  • Growth factors
  • Erythropoietin stimulating agents
  • Thrombopoietic agents
  • Iron supplements

Route of Administration:

  • Oral
  • Injectable

Distribution Channel:

  • Hospital pharmacies
  • Retail pharmacies
  • Online pharmacies
  • Drug stores

Region

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East & Africa

Frequently Asked Questions

The global radiation-induced myelosuppression treatment market is expected to reach a valuation of US$ 2.9 Bn in 2022.

The global Radiation-induced myelosuppression treatment market grew at a 3.4% CAGR between 2013 and 2021.

Increasing preference for non-invasive drug administration, along with the introduction of intravenous iron therapy are key trends driving radiation-induced myelosuppression treatment sales.

North America is projected to account for a dominant share of the global radiation-induced myelosuppression treatment market share during the forecast period.

The radiation-induced myelosuppression treatment market in Europe is anticipated to expand at a considerable pace over the assessment period.

Table of Content

1. Executive Summary

    1.1. Market Overview

    1.2. Market Analysis

    1.3. FMI Analysis and Recommendations

    1.4. Wheel of Fortune

2. Market Introduction

    2.1. Market Taxonomy

    2.2. Market Definition

    2.3. Inclusion and Exclusions

3. Radiation Induced Myelosuppression Treatment Market Opportunity Analysis

    3.1. Macro-Economic Factors

    3.2. Opportunity Analysis

4. Market Background

    4.1. Radiation Induced Myelosuppression Treatment Market Evolution

    4.2. Market Dynamics

        4.2.1. Drivers

        4.2.2. Restraints

        4.2.3. Trends

5. Macroeconomic Assumptions

6. Global Economic Outlook

    6.1. Gross Domestic Product by Region & Country, 2016 – 2021

7. Key Inclusions

    7.1. Key Regulations

    7.2. Pipeline Assessment

    7.3. Patient Treatment Regimen/Patient Journey

8. Global Market Analysis 2013–2021 and Forecast 2022–2028

    8.1. Market Value Share Analysis

    8.2. Y-o-Y Growth Analysis

    8.3. Absolute $ Opportunity

9. North America Radiation Induced Myelosuppression Treatment Market Analysis 2013–2021 and Forecast 2022–2028

    9.1. Introduction

    9.2. Historical Market Size (US$ Mn) Analysis By Country, 2013–2021

        9.2.1. U.S.

        9.2.2. Canada

    9.3. Market Size (US$ Mn) Forecast By Country, 2022–2028

    9.4. Historical Market Size (US$ Mn) Trend Analysis By Drug Class, 2013–2021

        9.4.1. Growth Factors

            9.4.1.1. Granulocyte Colony-Stimulating Factor

            9.4.1.2. Thrombopoietin Receptor Agonists

        9.4.2. Erythropoietin-stimulating Agents

        9.4.3. Thrombopoietic Agents

        9.4.4. Iron supplementation

        9.4.5. Others

    9.5. Market Size (US$ Mn) Forecast By Drug Class, 2022–2028

    9.6. Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2013–2021

        9.6.1. Oral

        9.6.2. Injectable

    9.7. Market Size (US$ Mn) Forecast By Route of Administration, 2022–2028

    9.8. Historical Market Size (US$ Mn) Trend Analysis By Indication, 2013–2021

        9.8.1. Anemia

        9.8.2. Neutropenia

        9.8.3. Thrombocytopenia

    9.9. Market Size (US$ Mn) Forecast By Indication, 2022–2028

    9.10. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2021

        9.10.1. Hospital Pharmacies

        9.10.2. Retail Pharmacies

        9.10.3. Drug Stores

        9.10.4. Online Pharmacies

    9.11. Market Size (US$ Mn) Forecast By Distribution Channel, 2022–2028

    9.12. Market Attractiveness Analysis

        9.12.1. By Country

        9.12.2. By Drug Class

        9.12.3. By Route of Administration

        9.12.4. By Indication

        9.12.5. By Distribution Channel

    9.13. Drivers and Restraints – Impact Analysis

10. Latin America Radiation Induced Myelosuppression Treatment Market Analysis 2013–2021 and Forecast 2022–2028

    10.1. Introduction

    10.2. Historical Market Size (US$ Mn) By Country, 2013–2021

        10.2.1. Brazil

        10.2.2. Mexico

        10.2.3. Argentina

        10.2.4. Rest of Latin America

    10.3. Market Size (US$ Mn) Forecast By Country, 2022–2028

    10.4. Historical Market Size (US$ Mn) Trend Analysis By Drug Class, 2013–2021

        10.4.1. Growth Factors

            10.4.1.1. Granulocyte Colony-Stimulating Factor

            10.4.1.2. Thrombopoietin Receptor Agonists

        10.4.2. Erythropoietin-stimulating Agents

        10.4.3. Thrombopoietic Agents

        10.4.4. Iron supplementation

        10.4.5. Others

    10.5. Market Size (US$ Mn) Forecast By Drug Class, 2022–2028

    10.6. Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2013–2021

        10.6.1. Oral

        10.6.2. Injectable

    10.7. Market Size (US$ Mn) Forecast By Route of Administration, 2022–2028

    10.8. Historical Market Size (US$ Mn) Trend Analysis By Indication, 2013–2021

        10.8.1. Anemia

        10.8.2. Neutropenia

        10.8.3. Thrombocytopenia

    10.9. Market Size (US$ Mn) Forecast By Indication, 2022–2028

    10.10. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2021

        10.10.1. Hospital Pharmacies

        10.10.2. Retail Pharmacies

        10.10.3. Drug Stores

        10.10.4. Online Pharmacies

    10.11. Market Size (US$ Mn) Forecast By Distribution Channel, 2022–2028

    10.12. Market Attractiveness Analysis

        10.12.1. By Country

        10.12.2. By Drug Class

        10.12.3. By Route of Administration

        10.12.4. By Indication

        10.12.5. By Distribution Channel

    10.13. Drivers and Restraints – Impact Analysis

11. Western Europe Radiation Induced Myelosuppression Treatment Market Analysis 2013–2021 and Forecast 2022–2028

    11.1. Introduction

    11.2. Historical Market Size (US$ Mn) By Country, 2013–2021

        11.2.1. Germany

        11.2.2. France

        11.2.3. U.K.

        11.2.4. Spain

        11.2.5. Italy

        11.2.6. Rest of Western Europe

    11.3. Market Size (US$ Mn) Forecast By Country, 2022–2028

    11.4. Historical Market Size (US$ Mn) Trend Analysis By Drug Class, 2013–2021

        11.4.1. Growth Factors

            11.4.1.1. Granulocyte Colony-Stimulating Factor

            11.4.1.2. Thrombopoietin Receptor Agonists

        11.4.2. Erythropoietin-stimulating Agents

        11.4.3. Thrombopoietic Agents

        11.4.4. Iron supplementation

        11.4.5. Others

    11.5. Market Size (US$ Mn) Forecast By Drug Class, 2022–2028

    11.6. Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2013–2021

        11.6.1. Oral

        11.6.2. Injectable

    11.7. Market Size (US$ Mn) Forecast By Route of Administration, 2022–2028

    11.8. Historical Market Size (US$ Mn) Trend Analysis By Indication, 2013–2021

        11.8.1. Anemia

        11.8.2. Neutropenia

        11.8.3. Thrombocytopenia

    11.9. Market Size (US$ Mn) Forecast By Indication, 2022–2028

    11.10. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2021

        11.10.1. Hospital Pharmacies

        11.10.2. Retail Pharmacies

        11.10.3. Drug Stores

        11.10.4. Online Pharmacies

    11.11. Market Size (US$ Mn) Forecast By Distribution Channel, 2022–2028

    11.12. Market Attractiveness Analysis

        11.12.1. By Country

        11.12.2. By Drug Class

        11.12.3. By Route of Administration

        11.12.4. By Indication

        11.12.5. By Distribution Channel

    11.13. Drivers and Restraints – Impact Analysis

12. Eastern Europe Radiation Induced Myelosuppression Treatment Market Analysis 2013–2021 and Forecast 2022–2028

    12.1. Introduction

    12.2. Historical Market Size (US$ Mn) By Country, 2013–2021

        12.2.1. Russia

        12.2.2. Poland

        12.2.3. Rest of Eastern Europe

    12.3. Market Size (US$ Mn) Forecast By Country, 2022–2028

    12.4. Historical Market Size (US$ Mn) Trend Analysis By Drug Class, 2013–2021

        12.4.1. Growth Factors

            12.4.1.1. Granulocyte Colony-Stimulating Factor

            12.4.1.2. Thrombopoietin Receptor Agonists

        12.4.2. Erythropoietin-stimulating Agents

        12.4.3. Thrombopoietic Agents

        12.4.4. Iron supplementation

        12.4.5. Others

    12.5. Market Size (US$ Mn) Forecast By Drug Class, 2022–2028

    12.6. Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2013–2021

        12.6.1. Oral

        12.6.2. Injectable

    12.7. Market Size (US$ Mn) Forecast By Route of Administration, 2022–2028

    12.8. Historical Market Size (US$ Mn) Trend Analysis By Indication, 2013–2021

        12.8.1. Anemia

        12.8.2. Neutropenia

        12.8.3. Thrombocytopenia

    12.9. Market Size (US$ Mn) Forecast By Indication, 2022–2028

    12.10. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2021

        12.10.1. Hospital Pharmacies

        12.10.2. Retail Pharmacies

        12.10.3. Drug Stores

        12.10.4. Online Pharmacies

    12.11. Market Size (US$ Mn) Forecast By Distribution Channel, 2022–2028

    12.12. Market Attractiveness Analysis

        12.12.1. By Country

        12.12.2. By Drug Class

        12.12.3. By Route of Administration

        12.12.4. By Indication

        12.12.5. By Distribution Channel

    12.13. Drivers and Restraints – Impact Analysis

13. Asia Pacific excluding China (APEC) Radiation Induced Myelosuppression Treatment Market Analysis 2013–2021 and Forecast 2022–2028

    13.1. Introduction

    13.2. Historical Market Size (US$ Mn) By Country, 2013–2021

        13.2.1. China

        13.2.2. India

        13.2.3. Australia and New Zealand

        13.2.4. ASEAN

        13.2.5. Rest of APAC

    13.3. Market Size (US$ Mn) Forecast By Country, 2022–2028

    13.4. Historical Market Size (US$ Mn) Trend Analysis By Drug Class, 2013–2021

        13.4.1. Growth Factors

            13.4.1.1. Granulocyte Colony-Stimulating Factor

            13.4.1.2. Thrombopoietin Receptor Agonists

        13.4.2. Erythropoietin-stimulating Agents

        13.4.3. Thrombopoietic Agents

        13.4.4. Iron supplementation

        13.4.5. Others

    13.5. Market Size (US$ Mn) Forecast By Drug Class, 2022–2028

    13.6. Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2013–2021

        13.6.1. Oral

        13.6.2. Injectable

    13.7. Market Size (US$ Mn) Forecast By Route of Administration, 2022–2028

    13.8. Historical Market Size (US$ Mn) Trend Analysis By Indication, 2013–2021

        13.8.1. Anemia

        13.8.2. Neutropenia

        13.8.3. Thrombocytopenia

    13.9. Market Size (US$ Mn) Forecast By Indication, 2022–2028

    13.10. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2021

        13.10.1. Hospital Pharmacies

        13.10.2. Retail Pharmacies

        13.10.3. Drug Stores

        13.10.4. Online Pharmacies

    13.11. Market Size (US$ Mn) Forecast By Distribution Channel, 2022–2028

    13.12. Market Attractiveness Analysis

        13.12.1. By Country

        13.12.2. By Drug Class

        13.12.3. By Route of Administration

        13.12.4. By Indication

        13.12.5. By Distribution Channel

    13.13. Drivers and Restraints – Impact Analysis

14. Japan Radiation Induced Myelosuppression Treatment Market Analysis 2013–2021 and Forecast 2022–2028

    14.1. Introduction

    14.2. Historical Market Size (US$ Mn) Trend Analysis By Drug Class, 2013–2021

        14.2.1. Growth Factors

            14.2.1.1. Granulocyte Colony-Stimulating Factor

            14.2.1.2. Thrombopoietin Receptor Agonists

        14.2.2. Erythropoietin-stimulating Agents

        14.2.3. Thrombopoietic Agents

        14.2.4. Iron supplementation

        14.2.5. Others

    14.3. Market Size (US$ Mn) Forecast By Drug Class, 2022–2028

    14.4. Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2013–2021

        14.4.1. Oral

        14.4.2. Injectable

    14.5. Market Size (US$ Mn) Forecast By Route of Administration, 2022–2028

    14.6. Historical Market Size (US$ Mn) Trend Analysis By Indication, 2013–2021

        14.6.1. Anemia

        14.6.2. Neutropenia

        14.6.3. Thrombocytopenia

    14.7. Market Size (US$ Mn) Forecast By Indication, 2022–2028

    14.8. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2021

        14.8.1. Hospital Pharmacies

        14.8.2. Retail Pharmacies

        14.8.3. Drug Stores

        14.8.4. Online Pharmacies

    14.9. Market Size (US$ Mn) Forecast By Distribution Channel, 2022–2028

    14.10. Market Attractiveness Analysis

        14.10.1. By Drug Class

        14.10.2. By Route of Administration

        14.10.3. By Indication

        14.10.4. By Distribution Channel

    14.11. Drivers and Restraints – Impact Analysis

15. MEA Radiation Induced Myelosuppression Treatment Market Analysis 2013–2021 and Forecast 2022–2028

    15.1. Introduction

    15.2. Historical Market Size (US$ Mn) By Country, 2013–2021

        15.2.1. GCC Countries

        15.2.2. South Africa

        15.2.3. Rest of MEA

    15.3. Market Size (US$ Mn) Forecast By Country, 2022–2028

    15.4. Historical Market Size (US$ Mn) Trend Analysis By Drug Class, 2013–2021

        15.4.1. Growth Factors

            15.4.1.1. Granulocyte Colony-Stimulating Factor

            15.4.1.2. Thrombopoietin Receptor Agonists

        15.4.2. Erythropoietin-stimulating Agents

        15.4.3. Thrombopoietic Agents

        15.4.4. Iron supplementation

        15.4.5. Others

    15.5. Market Size (US$ Mn) Forecast By Drug Class, 2022–2028

    15.6. Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2013–2021

        15.6.1. Oral

        15.6.2. Injectable

    15.7. Market Size (US$ Mn) Forecast By Route of Administration, 2022–2028

    15.8. Historical Market Size (US$ Mn) Trend Analysis By Indication, 2013–2021

        15.8.1. Anemia

        15.8.2. Neutropenia

        15.8.3. Thrombocytopenia

    15.9. Market Size (US$ Mn) Forecast By Indication, 2022–2028

    15.10. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2021

        15.10.1. Hospital Pharmacies

        15.10.2. Retail Pharmacies

        15.10.3. Drug Stores

        15.10.4. Online Pharmacies

    15.11. Market Size (US$ Mn) Forecast By Distribution Channel, 2022–2028

    15.12. Market Attractiveness Analysis

        15.12.1. By Country

        15.12.2. By Drug Class

        15.12.3. By Route of Administration

        15.12.4. By Indication

        15.12.5. By Distribution Channel

    15.13. Drivers and Restraints – Impact Analysis

16. Forecast Factors: Relevance and Impact

17. Forecast Assumptions

18. Competition Analysis

    18.1. Competition Dashboard

    18.2. Market Structure Analysis

    18.3. Company Deep Dive

        18.3.1. Amgen Inc.

            18.3.1.1. Overview

            18.3.1.2. Product and Application Portfolio

            18.3.1.3. Production Footprint

            18.3.1.4. Sales Footprint

            18.3.1.5. Channel Footprint

            18.3.1.6. Strategy

                18.3.1.6.1. Marketing Strategy

                18.3.1.6.2. Product Strategy

                18.3.1.6.3. Channel Strategy

        18.3.2. Novartis AG

        18.3.3. Teva Pharmaceutical Industries Ltd

        18.3.4. Mylan N.V.

        18.3.5. Pfizer Inc.

        18.3.6. Janssen Global Services, LLC (Johnson & Johnson)

        18.3.7. Partner Therapeutics, Inc.

        18.3.8. Mission Pharmacal Company

        18.3.9. Myelo Therapeutics GmbH

        18.3.10. Pluristem Therapeutics Inc.

19. Global Radiation Induced Myelosuppression Treatment Market Analysis 2013–2021 and Forecast 2022–2028, By Region

    19.1. Introduction / Key Findings

    19.2. Historical Market Size (US$ Mn) Trend Analysis By Region, 2013–2021

        19.2.1. North America

        19.2.2. Latin America

        19.2.3. Western Europe

        19.2.4. Eastern Europe

        19.2.5. Asia Pacific excluding Japan

        19.2.6. Japan

        19.2.7. Middle East and Africa

    19.3. Market Size (US$ Mn) Forecast By Region, 2022–2028

    19.4. Market Attractiveness Analysis By Region

20. Global Radiation Induced Myelosuppression Treatment Market Analysis 2013–2021 and Forecast 2022–2028, By Drug Class

    20.1. Introduction

    20.2. Historical Market Size (US$ Mn) Trend Analysis By Drug Class, 2013–2021

        20.2.1. Growth Factors

            20.2.1.1. Granulocyte Colony-Stimulating Factor

            20.2.1.2. Thrombopoietin Receptor Agonists

        20.2.2. Erythropoietin-stimulating Agents

        20.2.3. Thrombopoietic Agents

        20.2.4. Iron supplementation

        20.2.5. Others

    20.3. Market Size (US$ Mn) Forecast By Drug Class, 2022–2028

    20.4. Market Attractiveness Analysis By Drug Class

21. Global Radiation Induced Myelosuppression Treatment Market Analysis 2013–2021 and Forecast 2022–2028, By Route of Administration

    21.1. Introduction

    21.2. Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2013–2021

        21.2.1. Oral

        21.2.2. Injectable

    21.3. Market Size (US$ Mn) Forecast By Route of Administration, 2022–2028

    21.4. Market Attractiveness Analysis By Route of Administration

22. Global Radiation Induced Myelosuppression Treatment Market Analysis 2013–2021 and Forecast 2022–2028, By Indication

    22.1. Introduction

    22.2. Historical Market Size (US$ Mn) Trend Analysis By Indication, 2013–2021

        22.2.1. Anemia

        22.2.2. Neutropenia

        22.2.3. Thrombocytopenia

    22.3. Market Size (US$ Mn) Forecast By Indication, 2022–2028

    22.4. Market Attractiveness Analysis By Indication

23. Global Radiation Induced Myelosuppression Treatment Market Analysis 2013–2021 and Forecast 2022–2028, By Distribution Channel

    23.1. Introduction

    23.2. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2021

        23.2.1. Hospital Pharmacies

        23.2.2. Retail Pharmacies

        23.2.3. Drug Stores

        23.2.4. Online Pharmacies

    23.3. Market Size (US$ Mn) Forecast By Distribution Channel, 2022–2028

    23.4. Market Attractiveness Analysis By Distribution Channel

24. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 1: Radiation Induced Myelosuppression Treatment Market Pipeline Analysis (2021)

Table 2: North America Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Country

Table 3: North America Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Drug Class

Table 4: North America Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Route of Administration

Table 5: North America Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Indication

Table 6: North America Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Distribution Channel

Table 7: Latin America Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Country

Table 8: Latin America Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Drug Class

Table 9: Latin America Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Route of Administration

Table 10:Latin America Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Indication

Table 11:Latin America Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Distribution Channel

Table 12:Western Europe Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Country

Table 13:Western Europe Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Drug Class

Table 14:Western Europe Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Route of Administration

Table 15:Western Europe Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Indication

Table 16:Western Europe Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Distribution Channel

Table 17:Eastern Europe Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Country

Table 18:Eastern Europe Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Drug Class

Table 19:Eastern Europe Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Route of Administration

Table 20:Eastern Europe Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Indication

Table 21:Eastern Europe Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Distribution Channel

Table 22:APEJ Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Country

Table 23:APEJ Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Drug Class

Table 24:APEJ Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Route of Administration

Table 25:APEJ Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Indication

Table 26:APEJ Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Distribution Channel

Table 27:Japan Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Drug Class

Table 28:Japan Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Route of Administration

Table 29:Japan Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Indication

Table 30:Japan Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Distribution Channel

Table 31:MEA Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Country

Table 32:MEA Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Drug Class

Table 33:MEA Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Route of Administration

Table 34:MEA Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Indication

Table 35:MEA Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Distribution Channel

Table 36:Global Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Region

Table 37:Global Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Indication

Table 38:Global Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Route of Administration

Table 39:Global Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Distribution Channe

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 01: Clinical Programs for Radiation Induced Myelosuppression Treatment, by Indication

Figure 02: Clinical Programs for Radiation Induced Myelosuppression Treatment, by Phase

Figure 03: Global Radiation Induced Myelosuppression Treatment Market Absolute $ Opportunity, 2013–2028

Figure 04: Global Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis, 2013–2021

Figure 05: Global Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 06: North America Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis, 2013–2021

Figure 07: North America Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 08: North America Radiation Induced Myelosuppression Treatment Market Analysis by Country –2022 & 2028

Figure 09: North America Radiation Induced Myelosuppression Treatment Market Y-o-Y Growth Projections by Country, 2022 – 2028

Figure 10: North America Radiation Induced Myelosuppression Treatment Market Attractiveness Analysis by Country, 2022 – 2028

Figure 11: North America Radiation Induced Myelosuppression Treatment Market Analysis by Type–2022 & 2028

Figure 12: North America Radiation Induced Myelosuppression Treatment Market Y-o-Y Growth Projections by Type, 2022 – 2028

Figure 13: North America Radiation Induced Myelosuppression Treatment Market Attractiveness Analysis by Type, 2022 – 2028

Figure 14: North America Radiation Induced Myelosuppression Treatment Market Analysis by Indication – 2022 & 2028

Figure 15: North America Radiation Induced Myelosuppression Treatment Market Y-o-Y Growth Projections by Indication, 2022 – 2028

Figure 16: North America Radiation Induced Myelosuppression Treatment Market Attractiveness Analysis by Indication, 2022 – 2028

Figure 17: North America Radiation Induced Myelosuppression Treatment Market Analysis by Indication – 2022 & 2028

Figure 18: North America Radiation Induced Myelosuppression Treatment Market Y-o-Y Growth Projections by Indication, 2022 – 2028

Figure 19: North America Radiation Induced Myelosuppression Treatment Market Attractiveness Analysis by Indication, 2022 – 2028

Figure 20: North America Radiation Induced Myelosuppression Treatment Market Analysis by Distribution Channel – 2022 & 2028

Figure 21: North America Radiation Induced Myelosuppression Treatment Market Y-o-Y Growth Projections by Distribution Channel, 2022 – 2028

Figure 22: North America Radiation Induced Myelosuppression Treatment Market Attractiveness Analysis by Distribution Channel, 2022 – 2028

Figure 23: Latin America Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis, 2013–2021

Figure 24: Latin America Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 25: Latin America Radiation Induced Myelosuppression Treatment Market Analysis by Country –2022 & 2028

Figure 26: Latin America Radiation Induced Myelosuppression Treatment Market Y-o-Y Growth Projections by Country, 2022 – 2028

Figure 27: Latin America Radiation Induced Myelosuppression Treatment Market Attractiveness Analysis by Country, 2022 – 2028

Figure 28: Latin America Radiation Induced Myelosuppression Treatment Market Analysis by Type–2022 & 2028

Figure 29: Latin America Radiation Induced Myelosuppression Treatment Market Y-o-Y Growth Projections by Type, 2022 – 2028

Figure 30: Latin America Radiation Induced Myelosuppression Treatment Market Attractiveness Analysis by Type, 2022 – 2028

Figure 31: Latin America Radiation Induced Myelosuppression Treatment Market Analysis by Indication – 2022 & 2028

Figure 32: Latin America Radiation Induced Myelosuppression Treatment Market Y-o-Y Growth Projections by Indication, 2022 – 2028

Figure 33: Latin America Radiation Induced Myelosuppression Treatment Market Attractiveness Analysis by Indication, 2022 – 2028

Figure 34: Latin America Radiation Induced Myelosuppression Treatment Market Analysis by Indication – 2022 & 2028

Figure 35: Latin America Radiation Induced Myelosuppression Treatment Market Y-o-Y Growth Projections by Indication, 2022 – 2028

Figure 36: Latin America Radiation Induced Myelosuppression Treatment Market Attractiveness Analysis by Indication, 2022 – 2028

Figure 37: Latin America Radiation Induced Myelosuppression Treatment Market Analysis by Distribution Channel – 2022 & 2028

Figure 38: Latin America Radiation Induced Myelosuppression Treatment Market Y-o-Y Growth Projections by Distribution Channel, 2022 – 2028

Figure 39: Latin America Radiation Induced Myelosuppression Treatment Market Attractiveness Analysis by Distribution Channel, 2022 – 2028

Figure 40: Western Europe Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis, 2013–2021

Figure 41: Western Europe Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 42: Western Europe Radiation Induced Myelosuppression Treatment Market Analysis by Country –2022 & 2028

Figure 43: Western Europe Radiation Induced Myelosuppression Treatment Market Y-o-Y Growth Projections by Country, 2022 – 2028

Figure 44: Western Europe Radiation Induced Myelosuppression Treatment Market Attractiveness Analysis by Country, 2022 – 2028

Figure 45: Western Europe Radiation Induced Myelosuppression Treatment Market Analysis by Type–2022 & 2028

Figure 46: Western Europe Radiation Induced Myelosuppression Treatment Market Y-o-Y Growth Projections by Type, 2022 – 2028

Figure 47: Western Europe Radiation Induced Myelosuppression Treatment Market Attractiveness Analysis by Type, 2022 – 2028

Figure 48: Western Europe Radiation Induced Myelosuppression Treatment Market Analysis by Indication – 2022 & 2028

Figure 49: Western Europe Radiation Induced Myelosuppression Treatment Market Y-o-Y Growth Projections by Indication, 2022 – 2028

Figure 50: Western Europe Radiation Induced Myelosuppression Treatment Market Attractiveness Analysis by Indication, 2022 – 2028

Figure 51: Western Europe Radiation Induced Myelosuppression Treatment Market Analysis by Indication – 2022 & 2028

Figure 52: Western Europe Radiation Induced Myelosuppression Treatment Market Y-o-Y Growth Projections by Indication, 2022 – 2028

Figure 53: Western Europe Radiation Induced Myelosuppression Treatment Market Attractiveness Analysis by Indication, 2022 – 2028

Figure 54: Western Europe Radiation Induced Myelosuppression Treatment Market Analysis by Distribution Channel – 2022 & 2028

Figure 55: Western Europe Radiation Induced Myelosuppression Treatment Market Y-o-Y Growth Projections by Distribution Channel, 2022 – 2028

Figure 56: Western Europe Radiation Induced Myelosuppression Treatment Market Attractiveness Analysis by Distribution Channel, 2022 – 2028

Figure 57: Eastern Europe Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis, 2013–2021

Figure 58: Eastern Europe Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 59: Eastern Europe Radiation Induced Myelosuppression Treatment Market Analysis by Country –2022 & 2028

Figure 60: Eastern Europe Radiation Induced Myelosuppression Treatment Market Y-o-Y Growth Projections by Country, 2022 – 2028

Figure 61: Eastern Europe Radiation Induced Myelosuppression Treatment Market Attractiveness Analysis by Country, 2022 – 2028

Figure 62: Eastern Europe Radiation Induced Myelosuppression Treatment Market Analysis by Type–2022 & 2028

Figure 63: Eastern Europe Radiation Induced Myelosuppression Treatment Market Y-o-Y Growth Projections by Type, 2022 – 2028

Figure 64: Eastern Europe Radiation Induced Myelosuppression Treatment Market Attractiveness Analysis by Type, 2022 – 2028

Figure 65: Eastern Europe Radiation Induced Myelosuppression Treatment Market Analysis by Indication – 2022 & 2028

Figure 66: Eastern Europe Radiation Induced Myelosuppression Treatment Market Y-o-Y Growth Projections by Indication, 2022 – 2028

Figure 67: Eastern Europe Radiation Induced Myelosuppression Treatment Market Attractiveness Analysis by Indication, 2022 – 2028

Figure 68: Eastern Europe Radiation Induced Myelosuppression Treatment Market Analysis by Indication – 2022 & 2028

Figure 69: Eastern Europe Radiation Induced Myelosuppression Treatment Market Y-o-Y Growth Projections by Indication, 2022 – 2028

Figure 70: Eastern Europe Radiation Induced Myelosuppression Treatment Market Attractiveness Analysis by Indication, 2022 – 2028

Figure 71: Eastern Europe Radiation Induced Myelosuppression Treatment Market Analysis by Distribution Channel – 2022 & 2028

Figure 72: Eastern Europe Radiation Induced Myelosuppression Treatment Market Y-o-Y Growth Projections by Distribution Channel, 2022 – 2028

Figure 73: Eastern Europe Radiation Induced Myelosuppression Treatment Market Attractiveness Analysis by Distribution Channel, 2022 – 2028

Figure 74: APEJ Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis, 2013–2021

Figure 75: APEJ Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 76: APEJ Radiation Induced Myelosuppression Treatment Market Analysis by Country –2022 & 2028

Figure 77: APEJ Radiation Induced Myelosuppression Treatment Market Y-o-Y Growth Projections by Country, 2022 – 2028

Figure 78: APEJ Radiation Induced Myelosuppression Treatment Market Attractiveness Analysis by Country, 2022 – 2028

Figure 79: APEJ Radiation Induced Myelosuppression Treatment Market Analysis by Type–2022 & 2028

Figure 80: APEJ Radiation Induced Myelosuppression Treatment Market Y-o-Y Growth Projections by Type, 2022 – 2028

Figure 81: APEJ Radiation Induced Myelosuppression Treatment Market Attractiveness Analysis by Type, 2022 – 2028

Figure 82: APEJ Radiation Induced Myelosuppression Treatment Market Analysis by Indication – 2022 & 2028

Figure 83: APEJ Radiation Induced Myelosuppression Treatment Market Y-o-Y Growth Projections by Indication, 2022 – 2028

Figure 84: APEJ Radiation Induced Myelosuppression Treatment Market Attractiveness Analysis by Indication, 2022 – 2028

Figure 85: APEJ Radiation Induced Myelosuppression Treatment Market Analysis by Indication – 2022 & 2028

Figure 86: APEJ Radiation Induced Myelosuppression Treatment Market Y-o-Y Growth Projections by Indication, 2022 – 2028

Figure 87: APEJ Radiation Induced Myelosuppression Treatment Market Attractiveness Analysis by Indication, 2022 – 2028

Figure 88: APEJ Radiation Induced Myelosuppression Treatment Market Analysis by Distribution Channel – 2022 & 2028

Figure 89: APEJ Radiation Induced Myelosuppression Treatment Market Y-o-Y Growth Projections by Distribution Channel, 2022 – 2028

Figure 90: APEJ Radiation Induced Myelosuppression Treatment Market Attractiveness Analysis by Distribution Channel, 2022 – 2028

Figure 91: Japan Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis, 2013–2021

Figure 92: Japan Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 93: Japan Radiation Induced Myelosuppression Treatment Market Analysis by Type–2022 & 2028

Figure 94: Japan Radiation Induced Myelosuppression Treatment Market Y-o-Y Growth Projections by Type, 2022 – 2028

Figure 95: Japan Radiation Induced Myelosuppression Treatment Market Attractiveness Analysis by Type, 2022 – 2028

Figure 96: Japan Radiation Induced Myelosuppression Treatment Market Analysis by Indication – 2022 & 2028

Figure 97: Japan Radiation Induced Myelosuppression Treatment Market Y-o-Y Growth Projections by Indication, 2022 – 2028

Figure 98: Japan Radiation Induced Myelosuppression Treatment Market Attractiveness Analysis by Indication, 2022 – 2028

Figure 99: Japan Radiation Induced Myelosuppression Treatment Market Analysis by Indication – 2022 & 2028

Figure 100:Japan Radiation Induced Myelosuppression Treatment Market Y-o-Y Growth Projections by Indication, 2022 – 2028

Figure 101:Japan Radiation Induced Myelosuppression Treatment Market Attractiveness Analysis by Indication, 2022 – 2028

Figure 102:Japan Radiation Induced Myelosuppression Treatment Market Analysis by Distribution Channel – 2022 & 2028

Figure 103:Japan Radiation Induced Myelosuppression Treatment Market Y-o-Y Growth Projections by Distribution Channel, 2022 – 2028

Figure 104:Japan Radiation Induced Myelosuppression Treatment Market Attractiveness Analysis by Distribution Channel, 2022 – 2028

Figure 105:MEA Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis, 2013–2021

Figure 106:MEA Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 107:MEA Radiation Induced Myelosuppression Treatment Market Analysis by Country –2022 & 2028

Figure 108:MEA Radiation Induced Myelosuppression Treatment Market Y-o-Y Growth Projections by Country, 2022 – 2028

Figure 109:MEA Radiation Induced Myelosuppression Treatment Market Attractiveness Analysis by Country, 2022 – 2028

Figure 110:MEA Radiation Induced Myelosuppression Treatment Market Analysis by Type–2022 & 2028

Figure 111:MEA Radiation Induced Myelosuppression Treatment Market Y-o-Y Growth Projections by Type, 2022 – 2028

Figure 112:MEA Radiation Induced Myelosuppression Treatment Market Attractiveness Analysis by Type, 2022 – 2028

Figure 113:MEA Radiation Induced Myelosuppression Treatment Market Analysis by Indication – 2022 & 2028

Figure 114:MEA Radiation Induced Myelosuppression Treatment Market Y-o-Y Growth Projections by Indication, 2022 – 2028

Figure 115:MEA Radiation Induced Myelosuppression Treatment Market Attractiveness Analysis by Indication, 2022 – 2028

Figure 116:MEA Radiation Induced Myelosuppression Treatment Market Analysis by Indication – 2022 & 2028

Figure 117:MEA Radiation Induced Myelosuppression Treatment Market Y-o-Y Growth Projections by Indication, 2022 – 2028

Figure 118:MEA Radiation Induced Myelosuppression Treatment Market Attractiveness Analysis by Indication, 2022 – 2028

Figure 119:MEA Radiation Induced Myelosuppression Treatment Market Analysis by Distribution Channel – 2022 & 2028

Figure 120:MEA Radiation Induced Myelosuppression Treatment Market Y-o-Y Growth Projections by Distribution Channel, 2022 – 2028

Figure 121:MEA Radiation Induced Myelosuppression Treatment Market Attractiveness Analysis by Distribution Channel, 2022 – 2028

Figure 122:Global Radiation Induced Myelosuppression Treatment Market Analysis by Region –2022 & 2028

Figure 123:Global Radiation Induced Myelosuppression Treatment Market Y-o-Y Growth Projections by Region, 2022 – 2028

Figure 124:Global Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Region

Figure 125:Global Radiation Induced Myelosuppression Treatment Market Analysis by Indication–2022 & 2028

Figure 126:Global Radiation Induced Myelosuppression Treatment Market Y-o-Y Growth Projections by Indication, 2022 – 2028

Figure 127:Global Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Indication

Figure 128:Global Radiation Induced Myelosuppression Treatment Market Analysis by Route of Administration –2022 & 2028

Figure 129:Global Radiation Induced Myelosuppression Treatment Market Y-o-Y Growth Projections by Route of Administration, 2022 – 2028

Figure 130:Global Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Route of Administration

Figure 131:Global Radiation Induced Myelosuppression Treatment Market Analysis by Distribution Channel–2022 & 2028

Figure 132:Global Radiation Induced Myelosuppression Treatment Market Y-o-Y Growth Projections by Distribution Channel, 2022 – 2028

Figure 133:Global Radiation Induced Myelosuppression Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Distribution Channel

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Radiation-Induced Myelosuppression Treatment Market

Published : January 2022

Healthcare

Chemotherapy-Induced Myelosuppression Treatment Market

Published : March 2022

Healthcare

Cancer Diagnostics Market

Published : March 2021

Healthcare

Leukemia Therapeutics Treatment Market

Published : February 2022

Google translate

Radiation-Induced Myelosuppression Treatment Market